Why Stroke Patients Cry

 Treatment of uncontrolled crying after stroke

G Andersen 1

Affiliations 

• PMID: 7711357
 
• DOI: 10.2165/00002512-199506020-00003

Abstract

Uncontrolled crying after stroke is a disturbance of the motor concomitants of emotional affect. It manifests as stereotyped outbursts of crying that are excessive to an appropriate emotional response. The episodes can be triggered by almost any kind of emotional stimulus (happiness, excitement, sadness, just being looked at or talked to, the sight of a doctor, etc.) and can even occur without any obvious external or internal stimulus. The condition is socially embarrassing, and in the most severely affected patients the crying episodes can be so violent that they interfere with rehabilitation. Although frequent (1-year incidence is 20%), the condition often goes unrecognised because patients and relatives rarely complain about it spontaneously. Effective treatment has now been documented in 3 controlled studies of tricyclic antidepressants and the selective serotonin reuptake inhibitor citalopram. There seems to be a rationale for the latter approach to treatment, in that post-stroke pathological crying may be attributable to stroke-induced partial destruction of the serotonergic raphe nuclei in the brainstem or their ascending projections to the hemispheres. Although our knowledge of the aetiology and treatment of the condition is limited, and the need for further study is considerable, the present treatment possibilities can significantly improve quality of life for patients with this socially embarrassing and sometimes debilitating condition.

Similar articles

• Citalopram for post-stroke pathological crying.

  Andersen G, Vestergaard K, Riis JO.Lancet. 1993 Oct 2;342(8875):837-9. doi: 10.1016/0140-6736(93)92696-q.PMID: 8104273 Clinical Trial.
• Citalopram treatment of traumatic brain damage in a 6-year-old boy.

  Andersen G, Stylsvig M, Sunde N.J Neurotrauma. 1999 Apr;16(4):341-4. doi: 10.1089/neu.1999.16.341.PMID: 10225220
• Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission.

  Andersen G, Ingeman-Nielsen M, Vestergaard K, Riis JO.Stroke. 1994 May;25(5):1050-2. doi: 10.1161/01.str.25.5.1050.PMID: 7818634
• Epidemiology and treatment of post-stroke depression.

  Gustafson Y, Nilsson I, Mattsson M, Aström M, Bucht G.Drugs Aging. 1995 Oct;7(4):298-309. doi: 10.2165/00002512-199507040-00005.PMID: 8535057 Review.
• Neuropsychiatric consequences of stroke.

  Robinson RG.Annu Rev Med. 1997;48:217-29. doi: 10.1146/annurev.med.48.1.217.PMID: 9046957 Review.

See all similar articles

Cited by 4 articles

• Post-stroke depression inhibits improvement in activities of daily living in patients in a convalescent rehabilitation ward.

  Tsuchiya K, Fujita T, Sato D, Midorikawa M, Makiyama Y, Shimoda K, Tozato F.J Phys Ther Sci. 2016 Aug;28(8):2253-9. doi: 10.1589/jpts.28.2253. Epub 2016 Aug 31.PMID: 27630408 Free PMC article.
• Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

  Rampello L, Chiechio S, Nicoletti G, Alvano A, Vecchio I, Raffaele R, Malaguarnera M.Psychopharmacology (Berl). 2004 Apr;173(1-2):73-8. doi: 10.1007/s00213-003-1698-1. Epub 2003 Dec 17.PMID: 14685645 Clinical Trial.
• Citalopram--a review of pharmacological and clinical effects.

  Bezchlibnyk-Butler K, Aleksic I, Kennedy SH.J Psychiatry Neurosci. 2000 May;25(3):241-54.PMID: 10863884 Free PMC article. Review.
• Treatment of stroke in older patients. A state of the art review.

  Harper G.Drugs Aging. 1995 Jan;6(1):29-44. doi: 10.2165/00002512-199506010-00003.PMID: 7696777 Review.

References

1. 1. Postgrad Med J. 1990 Oct;66(780):818-21 - PubMed
2. 1. Drugs. 1992;43 Suppl 2:3-9; discussion 9-10 - PubMed
3. 1. N Engl J Med. 1985 Jun 6;312(23):1480-2 - PubMed
4. 1. Neurology. 1979 Oct;29(10):1435-6 - PubMed
5. 1. Psychopharmacology (Berl). 1985;86(3):253-7 - PubMed

Publication types

MeSH terms

Substances

ORIGINAL ARTICLE LINK